Application 074425
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PENTOXIFYLLINE | PENTOXIFYLLINE | TABLET, EXTENDED RELEASE;ORAL | 400MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-0357 | Pentoxifylline | Pentoxifylline | Mylan Pharmaceuticals Inc | ANDA | Current |
| 0378-0357 | Pentoxifylline | Pentoxifylline | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0615-4523 | Pentoxifylline | Pentoxifylline | NCS HealthCare of KY, Inc dba Vangard Labs | ANDA | Current |
| 51079-889 | Pentoxifylline | Pentoxifylline | Mylan Institutional Inc. | ANDA | Current |
| 53808-0758 | Pentoxifylline | Pentoxifylline | State of Florida DOH Central Pharmacy | ANDA | Current |